You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 47 No. 11, November 1990 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Neuropsychological Assessment of Monozygotic Twins Discordant for Schizophrenia

Terry E. Goldberg, PhD; J. Daniel Ragland, MA; E. Fuller Torrey, MD; James M. Gold, PhD; Llewellyn B. Bigelow, MD; Daniel R. Weinberger, MD

Arch Gen Psychiatry. 1990;47(11):1066-1072.


Abstract

• A comparison of monozygotic twins discordant for schizophrenia controls for genetic variance and reduces variance due to environmental circumstances, thus serving to highlight differences due to phenotypic-related variables. In this study, we assessed 16 such twin pairs on a wide range of neuropsychological tests. The affected twins tended to perform worse than their unaffected counterparts on most of the tests. Deficits were especially severe on tests of vigilance, memory, and concept formation, suggesting that dysfunction is greatest in the frontotemporal cortex. While manifest symptoms were not highly associated with neuropsychological scores, global level of functioning was. To address the issue of genetic liability, we also compared the sample of discordant unaffected twins with a sample of seven pairs of normal monozygotic twins. No significant differences between the groups were found for any neuropsychological test. In fact, the results suggest that neuropsychological dysfunction is a consistent feature of schizophrenia and that it is related primarily to the clinical disease process and not to genetic or nonspecific environmental factors.



Author Affiliations

From the Clinical Brain Disorders Branch, Intramural Research Program, National Institute of Mental Health, Neuroscience Center at St Elizabeths, Washington, DC.


Footnotes

Accepted for publication March 8, 1990.

Reprint requests to Clinical Brain Disorders Branch, Intramural Research Program, National Institute of Mental Health, Neuroscience Center at St Elizabeths, Washington, DC 20032 (Dr Goldberg).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Heritability of Changes in Brain Volume Over Time in Twin Pairs Discordant for Schizophrenia
Brans et al.
Arch Gen Psychiatry 2008;65:1259-1268.
ABSTRACT | FULL TEXT  

Executive Attention in Schizophrenic Males and the Impact of COMT Val108/158Met Genotype on Performance on the Attention Network Test
Opgen-Rhein et al.
Schizophr Bull 2008;34:1231-1239.
ABSTRACT | FULL TEXT  

Cognitive Improvement After Treatment With Second-Generation Antipsychotic Medications in First-Episode Schizophrenia: Is It a Practice Effect?
Goldberg et al.
Arch Gen Psychiatry 2007;64:1115-1122.
ABSTRACT | FULL TEXT  

Endophenotyping Schizophrenia
Braff et al.
Am. J. Psychiatry 2007;164:705-707.
FULL TEXT  

Substantial Shared Genetic Influences on Schizophrenia and Event-Related Potentials
Hall et al.
Am. J. Psychiatry 2007;164:804-812.
ABSTRACT | FULL TEXT  

Is COMT a Susceptibility Gene for Schizophrenia?
Williams et al.
Schizophr Bull 2007;33:635-641.
ABSTRACT | FULL TEXT  

Baseline Use of Concomitant Psychotropic Medications to Treat Schizophrenia in the CATIE Trial
Chakos et al.
Psychiatr. Serv. 2006;57:1094-1101.
ABSTRACT | FULL TEXT  

Generalized and Specific Cognitive Performance in Clinical High-Risk Cohorts: A Review Highlighting Potential Vulnerability Markers for Psychosis
Brewer et al.
Schizophr Bull 2006;32:538-555.
ABSTRACT | FULL TEXT  

Elaboration on Premorbid Intellectual Performance in Schizophrenia: Premorbid Intellectual Decline and Risk for Schizophrenia
Reichenberg et al.
Arch Gen Psychiatry 2005;62:1297-1304.
ABSTRACT | FULL TEXT  

Defining and Measuring Clinical Effectiveness in the Treatment of Schizophrenia
Nasrallah et al.
Psychiatr. Serv. 2005;56:273-282.
ABSTRACT | FULL TEXT  

A Summary of the FDA-NIMH-MATRICS Workshop on Clinical Trial Design for Neurocognitive Drugs for Schizophrenia
Buchanan et al.
Schizophr Bull 2005;31:5-19.
ABSTRACT | FULL TEXT  

Indicators of Genetic Liability to Schizophrenia: A Sibling Study of Neuropsychological Performance
Thompson et al.
Schizophr Bull 2005;31:85-96.
ABSTRACT | FULL TEXT  

Hippocampal Volumes in Schizophrenic Twins
van Erp et al.
Arch Gen Psychiatry 2004;61:346-353.
ABSTRACT | FULL TEXT  

Correlates of Treatment-Related Decision-Making Capacity Among Middle-Aged and Older Patients With Schizophrenia
Palmer et al.
Arch Gen Psychiatry 2004;61:230-236.
ABSTRACT | FULL TEXT  

No Evidence of a Homogeneous Frontal Neuropsychological Profile in a Sample of Schizophrenic Subjects
Gambini et al.
J. Neuropsychiatry Clin. Neurosi. 2003;15:53-57.
ABSTRACT | FULL TEXT  

Pharmacogenomics in schizophrenia: the quest for individualized therapy
Basile et al.
Hum Mol Genet 2002;11:2517-2530.
ABSTRACT | FULL TEXT  

Sustained attention deficit in bipolar disorder
CLARK et al.
Br. J. Psychiatry 2002;180:313-319.
ABSTRACT | FULL TEXT  

Generalized Cognitive Deficits in Schizophrenia: A Study of First-Episode Patients
Mohamed et al.
Arch Gen Psychiatry 1999;56:749-754.
ABSTRACT | FULL TEXT  

Structural Evaluation of the Prefrontal Cortex in Schizophrenia
Buchanan et al.
Am. J. Psychiatry 1998;155:1049-1055.
ABSTRACT | FULL TEXT  

A Quantitative Analysis of Smooth Pursuit Eye Tracking in Monozygotic Twins Discordant for Schizophrenia
Litman et al.
Arch Gen Psychiatry 1997;54:417-426.
ABSTRACT  

Neuropsychological Impairments in Deficit vs Nondeficit Forms of Schizophrenia
Buchanan et al.
Arch Gen Psychiatry 1994;51:804-811.
ABSTRACT  

Neuropsychological Functioning in Siblings Discordant for Schizophrenia and Healthy Volunteers
Cannon et al.
Arch Gen Psychiatry 1994;51:651-661.
ABSTRACT  

Schizophrenia and Temporal Lobe Epilepsy: A Neuropsychological Analysis
Gold et al.
Arch Gen Psychiatry 1994;51:265-272.
ABSTRACT  

Neuropsychological Deficits in Neuroleptic Naive Patients With First-Episode Schizophrenia
Saykin et al.
Arch Gen Psychiatry 1994;51:124-131.
ABSTRACT  

The Deficit Syndrome in Schizophrenia: Psychoanalytic and Neurobiological Perspectives
Willick
J Am Psychoanal Assoc 1993;41:1135-1157.
ABSTRACT  

Progress in Psychiatry- First of Two Parts
Michels and Marzuk
NEJM 1993;329:552-560.
FULL TEXT  

Regional Cerebral Blood Flow in Monozygotic Twins Discordant and Concordant for Schizophrenia
Berman et al.
Arch Gen Psychiatry 1992;49:927-934.
ABSTRACT  

Matching for Education in Studies of Schizophrenia
Resnick
Arch Gen Psychiatry 1992;49:246-246.
ABSTRACT  

Neuropsychological Performance in the Unaffected Twin
Green
Arch Gen Psychiatry 1992;49:247-247.
ABSTRACT  

Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia
Egan et al.
Proc. Natl. Acad. Sci. USA 2001;98:6917-6922.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.